TherapeuticsMD (TXMD) Operating Income Growth (3y) (2014 - 2026)
TherapeuticsMD (TXMD) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 40.17% |
| 10 | TherapeuticsMD | 278,799.99 | -8.14 Mn | - | 35.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.28% |
| Dec 31, 2025 | -26.66% |
| Sep 30, 2025 | 60.99% |
| Jun 30, 2025 | 63.97% |
| Mar 31, 2025 | 58.46% |
| Dec 31, 2024 | 73.59% |
| Sep 30, 2024 | 69.49% |
| Jun 30, 2024 | 57.04% |
| Mar 31, 2024 | 66.09% |
| Dec 31, 2023 | 64.03% |
| Sep 30, 2023 | 58.59% |
| Jun 30, 2023 | 62.00% |
| Mar 31, 2023 | 62.59% |
| Dec 31, 2022 | 45.67% |
| Sep 30, 2022 | 18.75% |
| Jun 30, 2022 | 29.07% |
| Mar 31, 2022 | 22.30% |
| Dec 31, 2021 | 2.45% |
| Sep 30, 2021 | -5.13% |
| Jun 30, 2021 | -2.13% |